ATP13A2 and Parkinson disease: Elevated ATP13A2 expression reduces intracellular α-synuclein levels via increased externalization of exosome-associated α-synuclein, which could explain why the surviving neurons of the substantia nigra pars compacta in sporadic PD patients exhibit ATP13A2 overexpression [39].